How many patents does
Wyeth have?
patents
8,367
families
1,182
granted
2,003
applications
6,364
US
1,472
EP
836
CN
504
WO
377
JP
324
KR
241
GB
2
RoW
4,611
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Wyeth
Top ten assignees appearing on patents
2009 - 2018
| wyeth | 6658 |
| janssen alzheimer immunotherapy | 204 |
| wyeth holdings corporation | 170 |
| zoetis w | 103 |
| elan pharma international | 77 |
| zoetis services | 76 |
| medimmune | 74 |
| nestec | 69 |
| elan pharmaceuticals | 43 |
| progenics pharmaceuticals | 39 |
2018
| wyeth | 190 |
| zoetis services | 13 |
| wyeth holdings corporation | 6 |
| nestec | 5 |
| ablynx | 4 |
| pfizer italia | 4 |
| aptevo research and development | 3 |
| progenics pharmaceuticals | 2 |
| zoetis w | 1 |
| ziarco | 1 |
Wyeth
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| novel immunogenic compositions for the prevention and treatment of meningococcal disease | 127 | 2001 |
| triazine compounds as p13 kinase and mtor inhibitors | 80 | 2008 |
| circovirus sequences associated with piglet weight loss disease (pwd) | 77 | 1997 |
| multivalent pneumococcal polysaccharide-protein conjugate composition | 76 | 2005 |
| maleate salts of (e)-n-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-qu… 🛈 | 73 | 2007 |
| prevention and treatment of amyloidogenic disease | 64 | 1997 |
| novel formulations which stabilize and inhibit precipitation of immunogenic compositions | 59 | 2006 |
| compositions relating to a mutant clostridium difficile toxin and methods thereof | 58 | 2011 |
| oral formulations and lipophilic salts of methylnaltrexone | 57 | 2010 |
| designer osteogenic proteins | 56 | 2010 |